Tying Advanced Biomanufacturing to a Clinic
Connecting clinical centers to industrial-grade autologous therapy manufacturing enhances therapeutics and processing efficiency.| GEN - Genetic Engineering and Biotechnology News
Simtra BioPharma Solutions advances sterile injectable manufacturing through major expansions in the U.S. and Germany, leveraging strategic partnerships and technical innovation to accelerate complex biologics, including ADCs and GLP-1 therapies, for global pharmaceutical clients. The post Simtra BioPharma Expands Global Footprint appeared first on GEN - Genetic Engineering and Biotechnology News.| GEN – Genetic Engineering and Biotechnology News
An academia-industry collaboration has developed a new sampling algorithm for Design of Experiment (DoE), which can explain its trade-offs between multiple variables. They hope it will democratize experimental design beyond specialist data scientists. The post Researchers Develop Intelligent Model for Aiding Design of Experiment appeared first on GEN - Genetic Engineering and Biotechnology News.| GEN – Genetic Engineering and Biotechnology News
Reducing the number of manual steps involved in cell therapy production using automation would help the industry reduce staffing costs, improve consistency, and help more patients gain access to these potentially lifesaving medicines, say researchers. The post Reduce Staffing Costs and Boost Access with Cell Therapy Automation appeared first on GEN - Genetic Engineering and Biotechnology News.| GEN – Genetic Engineering and Biotechnology News
This new, functionalized 3D chimeric protein scaffold recapitulates the physiological interactions of pluripotent stem cells with surrounding extracellular matrix, thus better mimicking human tissue. It offers up to 25-fold hiPSC proliferation. The post Functionalized Fibrin Gel Spurs In-Gel Production of hiPSCs appeared first on GEN - Genetic Engineering and Biotechnology News.| GEN – Genetic Engineering and Biotechnology News
In this GEN webinar, Nik Ekman will discuss critical considerations for scaling cell therapy processes from research through commercialization. The post Scaling Cell Therapy Development from Research to Commercialization appeared first on GEN - Genetic Engineering and Biotechnology News.| GEN – Genetic Engineering and Biotechnology News
By sustaining higher viable cell densities, extending culture duration, and enabling continuous product harvest, perfusion cell culture allows manufacturers to increase volumetric productivity while reducing cost of goods. The post Scaling Perfusion: How Small-Scale ATF Systems Bridge the Gap to Commercial mAb Manufacturing appeared first on GEN - Genetic Engineering and Biotechnology News.| GEN – Genetic Engineering and Biotechnology News
In this GEN webinar, LV expert Brianna Jayanthi, PhD, will discuss how Asimov's LV Edge Producer and Packaging Systems are leading to higher-quality, higher-productivity cell lines to support clinical and commercial LV therapies. The post Next-Gen Lentiviral Vector Manufacturing: Improving Scalability, Control, and Quality appeared first on GEN - Genetic Engineering and Biotechnology News.| GEN – Genetic Engineering and Biotechnology News
Connecting clinical centers to industrial-grade autologous therapy manufacturing enhances therapeutics and processing efficiency.| GEN - Genetic Engineering and Biotechnology News
The invention of CRISPR and DNA sequencing has provided the necessary tools for rapidly engineering CHO cells along with a parts list.| GEN - Genetic Engineering and Biotechnology News
